Concepedia

Selina Moy

SM

12

Publications

490

Citations

11

H-Index

1996

Active since

Affiliations

Astellas Pharma (United States)(Current)

Astellas Pharma (Netherlands)

Astellas Pharma (Japan)

PharmAccess Group

Rush University Medical Center

Selina Moy is an author at Astellas Pharma (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1996–2022

12

Publications

12

Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study

Marek Malík, E. Marcel van Gelderen, J H Lee et al. · Clinical Pharmacology & Therapeutics · 2012 · 147 citations

Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor

Angela James, Catherine C. Smith, Mark R. Litzow et al. · Clinical Pharmacokinetics · 2020 · 67 citations · Full text

Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder

Charlotte Eltink, Jennifer Lee, Marloes Schaddelee et al. · International Journal of Clinical Pharmacology and Therapeutics · 2012 · 54 citations

An HPLC/MS/MS assay for tacrolimus in patient blood samples Correlation with results of an ELISA assay

Ala M. Alak, Selina Moy, Melissa Cook et al. · Journal of Pharmaceutical and Biomedical Analysis · 1997 · 46 citations

, , +4

Role of Cytochrome P450 Isoenzymes 3A and 2D6 in the In Vivo Metabolism of Mirabegron, a β3-Adrenoceptor Agonist

Jennifer Lee, Selina Moy, John Meijer et al. · Clinical Drug Investigation · 2013 · 39 citations

, , +8

Rows per page

1–5 of 12